DGS Capital Management LLC reduced its stake in shares of Blue Owl Capital Co. (NYSE:OBDC – Free Report) by 4.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,752 shares of the company’s stock after selling 828 shares during the quarter. DGS Capital Management LLC’s holdings in Blue Owl Capital were worth $273,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in OBDC. National Bank of Canada FI bought a new position in Blue Owl Capital in the second quarter worth approximately $26,000. CWM LLC lifted its stake in Blue Owl Capital by 98.6% in the second quarter. CWM LLC now owns 2,079 shares of the company’s stock worth $32,000 after acquiring an additional 1,032 shares during the period. Rothschild Investment LLC bought a new position in Blue Owl Capital during the 2nd quarter worth about $61,000. Zions Bancorporation N.A. bought a new stake in shares of Blue Owl Capital in the 2nd quarter valued at about $61,000. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Blue Owl Capital by 604.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 4,172 shares of the company’s stock worth $65,000 after purchasing an additional 3,580 shares during the period. 42.83% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on OBDC shares. Compass Point raised shares of Blue Owl Capital to a “strong-buy” rating in a report on Monday, August 19th. Keefe, Bruyette & Woods reaffirmed an “underperform” rating and set a $14.00 target price (down previously from $15.50) on shares of Blue Owl Capital in a research report on Thursday. Wells Fargo & Company boosted their price target on Blue Owl Capital from $14.00 to $14.50 and gave the stock an “underweight” rating in a research report on Tuesday, October 29th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Blue Owl Capital in a research report on Tuesday, November 19th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Blue Owl Capital currently has a consensus rating of “Hold” and a consensus price target of $15.86.
Blue Owl Capital Stock Performance
Shares of OBDC stock opened at $15.29 on Friday. Blue Owl Capital Co. has a 12-month low of $13.98 and a 12-month high of $16.91. The business’s fifty day simple moving average is $15.07 and its 200-day simple moving average is $15.21. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.30. The company has a market cap of $5.96 billion, a PE ratio of 9.49 and a beta of 0.85.
Blue Owl Capital Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be given a dividend of $0.37 per share. This is a positive change from Blue Owl Capital’s previous quarterly dividend of $0.06. This represents a $1.48 annualized dividend and a yield of 9.68%. The ex-dividend date is Tuesday, December 31st. Blue Owl Capital’s dividend payout ratio is currently 91.93%.
About Blue Owl Capital
Blue Owl Capital Corporation is a business development company. It specializes in direct and fund of fund investments. The fund makes investments in senior secured, direct lending or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments, first lien, unitranche, and second lien term loans and common equity investments.
Read More
- Five stocks we like better than Blue Owl Capital
- 3 Healthcare Dividend Stocks to Buy
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- GRAIL: Biotech Stock Targeting $100B Cancer Market
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 12/9 – 12/13
Want to see what other hedge funds are holding OBDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Blue Owl Capital Co. (NYSE:OBDC – Free Report).
Receive News & Ratings for Blue Owl Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Owl Capital and related companies with MarketBeat.com's FREE daily email newsletter.